You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Bulk Pharmaceutical API Sources for ALCLOMETASONE DIPROPIONATE


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for ALCLOMETASONE DIPROPIONATE

Vendor Vendor Homepage Vendor Sku API Url
Hangzhou APIChem Technology ⤷  Get Started Free AC-3530 ⤷  Get Started Free
Molport ⤷  Get Started Free MolPort-005-943-443 ⤷  Get Started Free
AKos Consulting & Solutions ⤷  Get Started Free AKOS015896564 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for Alclometasone Dipropionate

Last updated: July 30, 2025

Introduction

Alclometasone dipropionate is a synthetic corticosteroid used primarily for its anti-inflammatory, antipruritic, and vasoconstrictive properties. It is prescribed for inflammatory skin conditions such as eczema, dermatitis, and psoriasis. As a topical corticosteroid, the quality and reliability of its active pharmaceutical ingredient (API) supply are crucial for manufacturers, healthcare providers, and patients. This article provides a comprehensive analysis of the global sources of bulk alclometasone dipropionate, emphasizing reputable suppliers, manufacturing hubs, and procurement considerations essential for industry stakeholders.

Overview of Alclometasone Dipropionate API

Chemical Profile:
Alclometasone dipropionate is a synthetic corticosteroid characterized by its potent anti-inflammatory activity. Its chemical structure includes a corticosteroid backbone with esterified side chains, which influence its potency and pharmacokinetics. The API must meet strict specifications regarding purity, stability, and bioequivalence.

Manufacturing Process:
The synthesis involves multi-step chemical reactions, including corticosteroid core derivation, chlorination, and esterification. This complexity necessitates high-quality manufacturing practices to minimize contamination and ensure batch-to-batch consistency.

Regulatory Status:
Approved in various jurisdictions, including the US (FDA), EU (EMA), and other regulatory agencies, production of alclometasone dipropionate API must comply with Good Manufacturing Practices (GMP). Suppliers should possess relevant certifications to assure compliance and quality.

Global API Manufacturing Hubs for Alclometasone Dipropionate

  1. India

India is a prominent hub for generic and specialty pharmaceutical ingredients, including corticosteroid APIs like alclometasone dipropionate. Indian manufacturers leverage cost-effective production, robust export infrastructure, and extensive R&D capabilities. Key companies include:

  • Sun Pharma: Known for comprehensive API manufacturing, Sun Pharma offers corticosteroid APIs with strict compliance to international standards.
  • Laurus Labs: Specializes in steroid APIs, including corticosteroids, and supplies to global markets after rigorous quality assurance.
  • Aurobindo Pharma: Offers a range of steroid APIs, backed by GMP-certified facilities.

India’s API industry benefits from a supportive regulatory environment, skilled workforce, and competitive pricing, making it a top source for global buyers.

  1. China

China continues to dominate API manufacturing, especially for corticosteroids, due to its large-scale production capacities and cost advantages. Chinese firms typically serve as bulk suppliers for multinational pharmaceutical companies. Notable companies include:

  • Hepalink: Specializes in steroidal APIs and intermediates, providing high-quality products with global certification.
  • North China Pharmaceutical Group Corporation (NCPC): Produces a wide range of corticosteroid APIs, including alclometasone dipropionate.
  • Shandong Xinhua Pharmaceutical: Offers steroid APIs, with a focus on quality control and regulatory compliance.

Chinese API producers often possess extensive production experience, advanced synthesis technology, and established distribution networks for global exports.

  1. Europe

European manufacturers primarily supply high-value, high-quality APIs due to stringent regulatory standards and emphasis on GMP compliance. Companies include:

  • Boehringer Ingelheim: Known for pharmaceutical intermediates and APIs, including corticosteroids, with high-quality GMP-certified products.
  • Siegfried AG: Offers custom synthesis and reliable supply of corticosteroid APIs suited for pharmaceutical partners.
  • Levochem (part of Celon Pharma): Supplies steroid APIs with a focus on regulatory standards and quality assurance.

European sources tend to operate at higher cost but offer superior quality, consistency, and regulatory compliance, making them preferred for premium markets.

  1. United States and Other North American Sources

While the US has a more limited API manufacturing landscape compared to India or China, some firms engage in advanced synthesis and custom manufacturing:

  • Albany Molecular Research Inc. (AMRI): Provides contract manufacturing and custom synthesis of corticosteroids for pharmaceutical clients.
  • Catalent Pharma Solutions: Offers regulatory-compliant APIs and intermediates, including corticosteroids, for specialized applications.

North American providers focus on innovation, high-quality standards, and supply chain security, though at higher prices.

Procurement Considerations for API Buyers

  • Regulatory Compliance: Ensure suppliers adhere to GMP and possess valid certifications (e.g., US FDA, EU GMP).
  • Quality Assurance: Review third-party audits, stability data, and batch records to validate API quality.
  • Pricing and Lead Times: Balance cost considerations with quality and delivery timelines, especially amid supply chain disruptions.
  • Supply Chain Resilience: Diversify suppliers across regions to mitigate risks associated with geopolitical or pandemic-related disruptions.
  • Environmental and Ethical Standards: Verify sustainable and ethical sourcing practices to align with corporate social responsibility policies.

Emerging Trends Influencing API Sourcing

  • Localization and Capacity Expansion: Regional API manufacturing capacity expansion, notably in Asia and Eastern Europe, aims to improve supply security.
  • Regulatory Harmonization: Increasing alignment of global regulations simplifies import/export processes and quality validation.
  • Supply Chain Transparency: Enhanced transparency and traceability bolster confidence in API sources amid rising quality concerns.

Conclusion

Manufacturers seeking bulk alclometasone dipropionate API have diverse sourcing options across the globe. Indian and Chinese suppliers dominate due to cost advantages and extensive manufacturing infrastructure, whereas Europe and North America focus on premium quality and regulatory adherence. Strategic procurement involves balancing cost, quality, regulatory compliance, and supply chain resilience. As the demand for corticosteroid APIs persists, establishing robust supplier relationships and ensuring compliance remain critical.


Key Takeaways

  • India and China are primary global sources for alclometasone dipropionate API, offering cost-effective bulk manufacturing.
  • European and North American suppliers emphasize high-quality standards, regulatory compliance, and innovation.
  • Due diligence regarding GMP certification, quality assurance, and supply chain robustness is essential for procurement.
  • Market trends point toward regional capacity expansion and increased regulatory harmonization, improving supply stability.
  • Diversification of suppliers mitigates risks and ensures reliable API availability for pharmaceutical manufacturers.

FAQs

1. What are the main factors to consider when sourcing alclometasone dipropionate API?
Quality, regulatory compliance (GMP adherence), supplier reputation, pricing, lead times, and supply chain resilience are essential considerations for sourcing API efficiently and safely.

2. Which countries are the leading producers of corticosteroid APIs like alclometasone dipropionate?
India and China are the dominant producers globally, with Europe and North America providing high-quality specialized sources.

3. How does regulatory compliance impact API sourcing decisions?
Regulatory compliance ensures product safety, efficacy, and legal marketability. Suppliers with GMP certificates and adherence to international standards accelerate approval processes and reduce compliance risk.

4. Are there alternatives to traditional suppliers for alclometasone dipropionate API?
Yes. Contract manufacturing organizations (CMOs) and custom synthesis firms offer tailored production options, especially for niche or high-purity requirements.

5. What trends are shaping the future of API sourcing for corticosteroids?
Growing regional production capacity, regulatory harmonization, supply chain transparency, and focus on sustainable sourcing are key trends enhancing API sourcing stability.


Sources:
[1] Pharmaceutical Technology, Corticosteroid API Market Review, 2022.
[2] World Health Organization, Guide on Pharmaceutical Raw Materials, 2021.
[3] European Medicines Agency, GMP Certification Guidelines, 2022.
[4] Industry Reports, API Manufacturing Capacity Analysis, 2023.
[5] Company disclosures and official websites of Sun Pharma, Hepalink, Boehringer Ingelheim, and others.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.